This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...

Since my previous article, shares of Abbott Laboratories have returned 10% versus ... and the exit of the ZonePerfect product line in the nutrition business (0.2%), ABT's organic sales would ...

Investors happily greeted the latest news from Abbott Laboratories (NYSE ... Much of the company's top-line growth was due to its medical devices segment, happily by far the largest of its ...

Looking at Abbott Laboratories, an investor could make an assessment about a stock's long term prospects using a moving average and trend line. If they believe a stock will remain above the moving ...

Abbott Laboratories will announce its Q3 results on the morning of 16th October, with earnings and topline growth largely expected to be in line with the Q2 trend. A year ago, all of Abbott's ...

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing in Abbott Laboratories ... this product line has been Abbott's ...

Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Ltd., Linde plc and Abbott Laboratories, as well as a micro-cap stock Value Line ...

Abbott Laboratories is one of the world's leading ... Over the past few years, this product line has been Abbott's most important growth driver. The company is doubling down.